Dear Kandice,

Thank you so much for your fast response. We’re absolutely delighted that you’d like to attend. Your presence and insights would be a real asset to the conference, and we would very much look forward to welcoming you in Berlin.

We completely understand the uncertainty around your travel budget and appreciate your openness. On our side, we’re still awaiting final confirmation from several sponsors, so unfortunately we’re not yet in a position to say to what extent we might be able to offer financial support. That said, please rest assured that we will do everything we can on our end to support your participation. We expect to have a clearer picture well before October 1 and I’ll be sure to keep you updated as things develop.

Also, just a small note: I’m not a professor ... (yet). :)

Kind regards,
Stephanie


On 16.07.25 17:50, Tanner, Kandice (NIH/NCI) [E] wrote:

Dear Prof. Möllmert,

Thank you for your kind invitation. I would very much like to attend.

 

I want to be transparent regarding our funding for travel in the upcoming year, as it is currently uncertain. While I am confident that we will be able to participate, I am less confident about our travel budget,  a clearer picture of our budget will be known on October 1st.

 

Please let me know if this degree of uncertainty is acceptable, as I would hate to cause last minute changes to your program.

 

Many thanks

Kandice

 

 

Kandice Tanner Ph.D.

Senior Investigator, Chief, Tissue Morphodynamics Section

Lab of Cell Biology

Center for Cancer Research

Bldg 37, Rm 2132B

37 Convent Dr,

Bethesda, MD

240-760-6882

 

From: Stephanie Möllmert <stephanie.moellmert@mpl.mpg.de>
Date: Monday, July 14, 2025 at 6:42 AM
To: "Tanner, Kandice (NIH/NCI) [E]" <kandice.tanner@nih.gov>
Subject: [EXTERNAL] Invitation: Keynote at BioBrillouin 2025, Berlin (Nov 25–27)

 

Dear Prof Tanner,

On behalf of the Scientific Organizing Committee, I have the honor to invite you to give a keynote talk at the upcoming 9th International BioBrillouin Conference, which will take place in Berlin, at the conference venue of the Max Planck Society (Harnack-Haus) on 25–27 November 2025.

This event serves as a venue where experts and leading scientists from around the world working on Brillouin Light Scattering Spectroscopy for biological and biomedical applications meet once a year to share their latest advances, findings, and innovations in the field. In addition to two full days of keynote, invited and contributed talks, it will feature poster sessions and various social activities.

As part of our efforts to deepen our understanding of biomechanical imaging and its relevance to Brillouin light scattering, we would be delighted to include your perspective on recent advances in the field. Your research, bridging biophysics, cellular biology, and tissue mechanics, offers important insights into how physical forces and structural cues shape cellular behavior and tissue function. We believe your keynote would be a highlight of the conference and inspire valuable discussions on the integration of mechanical imaging techniques within the broader context of biomedical optics and mechanobiology.

Due to limited financial resources and the short-notice relocation, which has limited our ability to acquire more comprehensive sponsorship for this event (it was initially meant to happen in Harvard), we request that keynote speakers cover their own travel and accommodation costs. If this presents a difficulty, please let us know and we can look into the potential of providing a travel stipend for cases most needed, albeit subject to availability.

We would very much look forward to meeting you in Berlin, and please let me know at your earliest convenience, but no later than July 20th, if you will be able to attend to deliver a keynote talk.

All the best,

Stephanie

 

 

On behalf of the Scientific Organizing Committee:

Jochen Guck (Max Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin, Germany)

Kareem Elsayad (Medical University of Vienna, Austria)

Robert Prevedel (European Molecular Biology Laboratory - EMBL, Germany)

Francesca Palombo (Exeter University, United Kingdom)

Stephanie Möllmert (Max Planck Institute for the Science of Light, Germany)

Michael Monaghan (Trinity College Dublin, Ireland)

Thorsten Hamann (Norwegian University of Science and Technology, Norway)

 

-- 
Dr. Stephanie Möllmert
Research Group Leader
 
Max-Planck-Zentrum für Physik und Medizin
Cell Physics Division
Kussmaulallee 2
91054 Erlangen
Germany
 
Max Planck Institute for the Science of Light
Cell Physics Division
Staudtstr. 2
91058 Erlangen
Germany
 
Phone: +49 (0) 9131 8284530
Email: stephanie.moellmert@mpl.mpg.de
 
Homepage: www.gucklab.com

CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and are confident the content is safe.

 

-- 
Dr. Stephanie Möllmert
Research Group Leader

Max-Planck-Zentrum für Physik und Medizin
Cell Physics Division
Kussmaulallee 2
91054 Erlangen
Germany

Max Planck Institute for the Science of Light
Cell Physics Division
Staudtstr. 2
91058 Erlangen
Germany

Phone: +49 (0) 9131 8284530
Email: stephanie.moellmert@mpl.mpg.de

Homepage: www.gucklab.com